V(D)J recombination: How to tame a transposase

Immunological Reviews

Volumn 200, Issue , 2004, Pages 249-260

  Brandt, Vicky L ^a   Roth, David B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; IMMUNOGLOBULIN; INTEGRASE; RAG1 PROTEIN; RAG2 PROTEIN; TRANSPOSASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CHROMOSOME REARRANGEMENT; DNA REPAIR; DNA STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; GENE LOCUS; GENE TARGETING; GENETIC CODE; GENETIC RECOMBINATION; HUMAN; HYBRID; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; TRANSESTERIFICATION;

DNA-BINDING PROTEINS; ESTERIFICATION; GENE REARRANGEMENT, B-LYMPHOCYTE; GENE REARRANGEMENT, T-LYMPHOCYTE; HOMEODOMAIN PROTEINS; HUMANS; NUCLEAR PROTEINS; RECOMBINATION, GENETIC; TRANSPOSASES; VDJ RECOMBINASES;

EID: 3242883717     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2004.00161.x     Document Type: Review

References (80)

1. Tycko B, Sklar J. Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model. Cancer Cells 1990;2:1-8.
2. Vanasse GJ, Concannon P, Willerford DM. Regulated genomic instability and neoplasia in the lymphoid lineage. Blood 1999;94:3997-4010.
3. Roth DB. Restraining the V(D)J recombinase. Nat Rev Immunol 2003;3:656-666.
4. Hiom K, Melek M, Gellert M. DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocations. Cell 1998;94:463-470.
5. Agrawal A, Eastman QM, Schatz DG. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 1998;394:744-751.
6. van Gent DC, Ramsden DA, Gellert M. The RAG1 and RAG2 proteins establish the 12/23 rule in V(D)J recombination. Cell 1996;85:107-113.
7. Lewis SM, Hesse JE, Mizuuchi K, Gellert M. Novel strand exchanges in V(D)J recombination. Cell 1988;55:1099-1107.
8. Agrawal A, Schatz DG. RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination. Cell 1997;89:43-53.
9. Hiom K, Gellert M. Assembly of a 12/23 paired signal complex: a critical control point in V(D)J recombination. Mol Cell 1998;1:1011-1019.
10. Qiu JX, Kale SB, Yarnell Schultz H, Roth DB. Separation-of-function mutants reveal critical roles for RAG2 in both the cleavage and joining steps of V(D)J recombination. Mol Cell 2001;7:77-87.
11. Yarnall Schultz H, Landree MA, Qiu JX, Kale SB, Roth DB. Joining-deficient RAG1 mutants block V(D)J recombination in vivo and hairpin opening in vitro. Mol Cell 2001;7:65-75.
12. Huye LE, Purugganan MM, Jiang MM, Roth DB. Mutational analysis of all conserved basic amino acids in RAG-1 reveals catalytic, step arrest, and joining-deficient mutants in the V(D)J recombinase. Mol Cell Biol 2002;22:3460-3473.
13. Tsai CL, Drejer AH, Schatz DG. Evidence of a critical architectural function for the RAG proteins in end processing, protection, and joining in V(D)J recombination. Genes Dev 2002;16:1934-1949.
14. Roth DB, Craig NL. VDJ recombination: a transposase goes to work. Cell 1998;94:411-414.
15. van Gent DC, Mizuuchi K, Gellert M. Similarities between initiation of V(D)J recombination and retroviral integration. Science 1996;271:1592-1594.
16. Kennedy AK, Guhathakurta A, Kleckner N, Haniford DB. Tn10 transposition via a DNA hairpin intermediate. Cell 1998;95:125-134.
17. Bhasin A, Goryshin IY, Reznikoff WS. Hairpin formation in Tn5 transposition. J Biol Chem 1999;274:37021-37029.
18. Sakano H, Huppi K, Heinrich G, Tonegawa S. Sequences at the somatic recombination sites of immunoglobulin light-chain genes. Nature 1979;280:288-294.
19. Oettinger MA, Schatz DG, Gorka C, Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 1990;248:1517-1523.
20. Thompson CB. New insights into V(D)J recombination and its role in the evolution of the immune system. Immunity 1995;3:531-539.
21. Roth DB. From lymphocytes to sharks: V(D)J recombinase moves to the germline. Genome Biol 2000;1:reviews1014.1-1014.4.
22. Hansen JD, McBlane JF. Recombination-activating genes, transposition, and the lymphoid-specific combinatorial immune system: a common evolutionary connection. Curr Top Microbiol Immunol 2000;248:111-135.
23. Han J-O, Steen SB, Roth DB. Ku86 is not required for protection of signal ends or for formation of nonstandard V(D)J recombination products. Mol Cell Biol 1997;17:2226-2234.
24. Han J-O, Erskine LA, Purugganan MM, Stamato TD, Roth DB. V(D)J recombination intermediates and non-standard products in XRCC4-deficient cells. Nucleic Acids Res 1998;26:3769-3775.
25. Bogue MA, Wang C, Zhu C, Roth DB. V(D)J recombination in Ku86-deficient mice: distinct effects on coding, signal, and hybrid joint formation. Immunity 1997;7:37-47.
26. Bogue MA, Jhappan C, Roth DB. Analysis of variable (diversity) joining recombination in DNA-dependent protein kinase (DNA-PK)-deficient mice reveals DNA-PK-independent pathways for both signal and coding joint formation. Proc Natl Acad Sci USA 1998;95:15559-15564.
27. Melek M, Gellert M, van Gent DC. Rejoining of DNA by the RAG1 and RAG2 proteins. Science 1998;280:301-303.
28. Steen SB, Han J-O, Mundy C, Oettinger MA, Roth DB. Roles of the "dispensable" portions of RAG-1 and RAG-2 in V(D)J recombination. Mol Cell Biol 1999;19:3010-3017.
29. Melek M, Gellert M. RAG1/2-mediated resolution of transposition intermediates: two pathways and possible consequences. Cell 2000;101:625-633.
30. Kulkosky J, Jones KS, Katz RA, Mack JPG, Skalka AM. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol Cell Biol 1992;12:2331-2338.
31. Grindley NDF, Leschziner AE. DNA transposition: from a black box to a color monitor. Cell 1995;83:1063-1066.
32. Rice P, Mizuuchi K. Structure of the bacteriophage Mu transposase core: a common structural motif for DNA transposition and retroviral integration. Cell 1995;82:209-220.
33. Landree MA, Wibbenmeyer JA, Roth DB. Mutational analysis of RAG-1 and RAG-2 identifies three active site amino acids in RAG-1 critical for both cleavage steps of V(D)J recombination. Genes Dev 1999;13:3059-3069.
34. Hickman AB, Li Y, Mathew SV, May EW, Craig NL, Dyda F. Unexpected structural diversity in DNA recombination: the restriction endonuclease connection. Mol Cell 2000;5:1025-1034.
35. Kim DR, Dai Y, Mundy CL, Yang W, Oettinger MA. Mutations of acidic residues in RAG1 define the active site of the V(D)J recombinase. Genes Dev 1999;13:3070-3080.
36. Bujacz G, et al. High-resolution structure of the catalytic domain of avian sarcoma virus integrase. J Mol Biol 1995;253:333-346.
37. Bujacz G, et al. The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations. Structure 1996;4:89-96.
38. Goldgur Y, Dyda F, Hickman AB, Jenkins TM, Craigie R. Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc Natl Acad Sci USA 1998;95:9150-9154.
39. Maignan S, Guilloteau J-P, Zhou-Liu Q, Clement-Mella C, Mikol V. Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases. J Mol Biol 1998;282:359-368.
40. Fugmann SD, Villey IJ, Ptaszek LM, Schatz DG. Identification of two catalytic residues in RAG1 that define a single active site within the RAG1/RAG2 protein complex. Mol Cell 2000; 5:97-107.
41. Lovell S, Goryshin IY, Reznikoff WR, Rayment I. Two-metal active site binding of a Tn5 transposase synaptic complex. Nat Struct Biol 2002;9:278-281.
42. Lewis SM. The mechanism of V(D)J joining: lessons from molecular immunological and comparative analyses. Adv Immunol 1994;56:27-150.
43. Market E, Papavasiliou FN. V(D)J recombination and the evolution of the adaptive immune system. PLos Biol 2003;1:E16.
44. Roth DB, Menetski JP, Nakajima PB, Bosma MJ, Gellert M. V(D)J recombination: broken DNA molecules with covalently sealed (hairpin) coding ends in scid mouse thymocytes. Cell 1992;70:983-991.
45. Schlissel M, Constantinescu A, Morrow T, Baxter M, Peng A. Double-strand signal sequence breaks in V(D)J recombination are blunt, 5′-phosphorylated RAG-dependent, and cell cycle regulated. Genes Dev 1993;7:2520-2532.
46. Zhu C, Roth DB. Characterization of coding ends in thymocytes of scid mice: implications for the mechanism of V(D)J recombination. Immunity 1995;2:101-112.
47. Livak F, Schatz DG. T-cell receptor alpha locus V(D)J recombination by-products are abundant in thymocytes and mature T cells. Mol Cell Biol 1996;16:609-618.
48. Ramsden DA, Gellert M. Formation and resolution of double-strand break intermediates in V(D)J rearrangement. Genes Dev 1995;9:2409-2420.
49. Jones JM, Gellert M. Intermediates in V(D)J recombination: a stable RAG1/2 complex sequesters cleaved RSS ends. Proc Natl Acad Sci USA 2001;98:12926-12931.
50. Lewis S, Gifford A, Baltimore D. DNA elements are asymmetrically joined during the site-specific recombination of kappa immunoglobulin genes. Science 1985;228:677-685.
51. Hesse JE, Lieber MR, Gellert M, Mizuuchi K. Extrachromosomal DNA substrates in pre-B cells undergo inversion or deletion at immunoglobulin V(D)J joining signals. Cell 1987;49:775-783.
52. Sadofsky MJ. The RAG proteins in V(D)J recombination: more than just a nuclease. Nucleic Acids Res 2001;29:1399-1409.
53. Lewis SM, Hesse JE. Cutting and closing without recombination in V(D)J joining. EMBO J 1991;10:3631-3639.
54. Sheehan KM, Lieber MR. V(D)J recombination: signal and coding joint resolution are uncoupled and depend on parallel synapsis of the sites. Mol Cell Biol 1993;13:1363-1370.
55. Neiditch MB, Lee GS, Huye LE, Brandt VL, Roth DB. The V(D)J recombinase efficiently cleaves and transposes signal joints. Mol Cell 2002;9:871-878.
56. Zhu C, Bogue MA, Lim D-S, Hasty P, Roth DB. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 1996;86:379-389.
57. Marculescu R, Vanura K, Le T, Simon P, Jager U, Nadel B. Distinct t(7;9)(q34;q32) breakpoints in healthy individuals and individuals with T-ALL. Nat Genet 2003;33:342-344.
58. Neiditch MB, Lee GS, Landree MA, Roth DB. RAG transposase can capture and commit to target DNA before or after donor cleavage. Mol Cell Biol 2001;21:4302-4310.
59. Sakai J, Kleckner N. The Tn10 synaptic complex can capture a target DNA only after transposon excision. Cell 1997;89:205-214.
60. Bailin T, Mo X, Sadofsky MJ. A RAG1 and RAG2 tetramer complex is active in cleavage in V(D)J recombination. Mol Cell Biol 1999;19:4664-4671.
61. Swanson PC. A RAG-1/RAG-2 tetramer supports 12/23-regulated synapsis, cleavage, and transposition of V(D)J recombination signals. Mol Cell Biol 2002;22:7790-7801.
62. Mundy CL, Patenge N, Matthews AG, Oettinger MA. Assembly of the RAG1/RAG2 synaptic complex. Mol Cell Biol 2002;22:69-77.
63. Lee GS, Neiditch MB, Sinden RR, Roth DB. Targeted transposition by the V(D)J recombinase. Mol Cell Biol 2002;22:2068-2077.
64. Elkin SK, Matthews AG, Oettinger MA. The C-terminal portion of RAG2 protects against transposition in vitro. EMBO J 2003;22:1931-1938.
65. Swanson PC, Volkmer D, Wang L. Full-length RAG-2, and not full-length RAG-1, specifically suppresses RAG-mediated transposition, but not hybrid joint formation or disintegration. J Biol Chem 2004;279:4034-4044.
66. Tsai CL, Schatz DG. Regulation of RAG1/RAG2-mediated transposition by GTP and the C-terminal region of RAG2. EMBO J 2003;22:1922-1930.
67. Kuduvalli PN, Rao JE, Craig NL. Target DNA structure plays a critical role in Tn7 transposition. EMBO J 2001;20:924-932.
68. Rao JE, Miller PS, Craig NL. Recognition of triple-helical DNA structures by transposon Tn7. Proc Natl Acad Sci USA 2000;97:3936-3941.
69. Rao JE, Craig NL. Selective recognition of pyrimidine motif triplexes by a protein encoded by the bacterial transposon Tn7. J Mol Biol 2001;307:1161-1170.
70. Kabotyanski EB, Zhu C, Kallick DA, Roth DB. Hairpin opening by single-strand specific nucleases. Nucleic Acids Res 1995;23:3872-3881.
71. Messier TL, O'Neill JP, Hou SM, Nicklas JA, Finette BA. In vivo transposition mediated by V(D)J recombinase in human T lymphocytes. EMBO J 2003;22:1381-1388.
72. Lu M, Zhang N, Raimondi S, Ho AD. S1 nuclease hypersensitive sites in an oligopurine/oligopyrimidine DNA from the t(10;14) breakpoint cluster region. Nucleic Acids Res 1992;20:263-266.
73. Boehm T, et al. Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours. EMBO J 1989;8:2621-2631.
74. Han J-O, Steen SB, Roth DB. Intermolecular V(D)J recombination is prohibited specifically at the joining step. Mol Cell 1999;3:331-338.
75. Tevelev A, Schatz DG. Intermolecular V(D)J recombination. J Biol Chem 2000;275:8341-8348.
76. Sekiguchi JA, Whitlow S, Alt FW. Increased accumulation of hybrid V(D)J joins in cells expressing truncated versus full-length RAGs. Mol Cell 2001;8:1383-1390.
77. Carroll AM, Slack JK, Mu X. V(D)J recombination generates a high frequency of nonstandard TCR delta-associated rearrangements in thymocytes. J Immunol 1993;150:2222-2230.
78. Sollbach AE, Wu GE. Inversions produced during V(D)J rearrangement at IgH, the immunoglobulin heavy-chain locus. Mol Cell Biol 1995;15:671-681.
79. VanDyk LF, Wise TW, Moore BB, Meek K. Immunoglobulin DH recombination signal sequence targeting. J Immunol 1996;157:4005-4015.
80. Fish SM, Bosma MJ. Abnormal deletions in the T cell receptor delta locus of mouse thymocytes. Mol Cell Biol 1994;14:4455-4464.